Breast cancer
Conditions
Interventions
Breast cancer ADC treatment group:None
Sponsors
Henan Cancer Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with breast cancer by pathology; 2. Planned to receive antibody-drug conjugate (ADC) therapy; 3. Aged 18-70 years; 4. Aware of their condition; 5. Mentally normal, with good understanding and communication abilities, capable of completing questionnaires; 6. Patients voluntarily participate and are able to cooperate with the study; 7. Life expectancy >3 months.
Exclusion criteria
Exclusion criteria: 1. Patients with cognitive impairment or mental illness as assessed by the Mini-Mental State Examination (MMSE). 2. Patients who have experienced major disease changes within the past three months. 3. Pregnant or lactating women. 4. Individuals with limb amputation, mobility impairment, or other reasons that hinder cooperation. 5. Patients with contraindications specified by the manufacturer of the bioelectrical impedance analysis device, such as cardiovascular stent implantation, cardiac pacemaker installation, or artificial joint replacement.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skeletal Muscle Index (SMI);Visceral Fat Area (VFA);Incidence of total adverse events;Phase Angle (PhA); | — |
Countries
China
Contacts
Public ContactZhiqing Zhang
Medical Ethics Committee of Henan Provincial Tumor Hospital
Outcome results
None listed